For the year ending 2026-03-28, HAE made $1,334,027K in revenue. $97,308K in net income. Net profit margin of 7.29%.
| Income Statement | 2026-03-28 | 2025-03-29 | ||
|---|---|---|---|---|
| Net revenues | 1,334,027 | 1,360,824 | ||
| Cost of goods sold | 546,441 | 611,866 | ||
| Gross profit | 787,586 | 748,958 | ||
| Research and development | 59,766 | 62,722 | ||
| Selling, general and administrative | 442,421 | 436,789 | ||
| Impairment of intangible assets | - | 2,391 | ||
| Amortization of acquired intangible assets | 43,998 | 48,261 | ||
| Remeasurement of contingent consideration | -1,879 | -23,022 | ||
| Impairment of intangible assets | 86,546 | - | ||
| Total operating expenses | 630,852 | 527,141 | ||
| Operating income | 156,734 | 221,817 | ||
| Interest and other expense, net | -28,704 | -9,746 | ||
| Income before provision for income taxes | 128,030 | 212,071 | ||
| Provision for income taxes | 30,722 | 44,392 | ||
| Net income | 97,308 | 167,679 | ||
| Basic EPS | 2.06 | 3.33 | ||
| Diluted EPS | 2.05 | 3.31 | ||
| Basic Average Shares | 47,179,000 | 50,330,000 | ||
| Diluted Average Shares | 47,354,000 | 50,730,000 | ||
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)